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Summary
Background.— Acute heart failure (HF) carries high hospital mortality rates in older patients;
a multimarker strategy may help identify patients at high risk.
Aims.— To investigate prospectively the prognostic relevance of serum albumin and serum total
cholesterol (TC) in older patients with severe, acute HF.
Methods.— Usual prognostic variables were collected on admission in 207 consecutive patients
aged > 70 years with severe, acute HF. Serum albumin and serum TC were obtained soon after
clinical improvement.
Results.— Hospital mortality rate was 19%. Patients who died were similar to patients who
survived in terms of age, sex, heart rate, serum haemoglobin and left ventricular ejection frac-
tion. Patients who died had higher concentrations of B-type natriuretic peptide (BNP), blood
urea nitrogen, serum creatinine, C-reactive protein and serum troponin I, lower systolic blood
pressure, and lower concentrations of serum albumin and serum TC than patients who survived
(P < 0.01 for all). Serum albumin was the best independent predictor of hospital death (odds ratio
Abbreviations: BNP, B-type natriuretic peptide; HF, heart failure; LV, left ventricular; ROC, receiver operating characteristic; TC,
otal cholesterol.
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0.82 [0.74—0.90], P < 0.001), with blood urea nitrogen (P = 0.02) and log (BNP) (P = 0.02). A sim-
ple risk score based on serum albumin (< 3 g/dL; 2 points), BNP (> 840 pg/mL; 1 point) and blood
urea nitrogen (> 15.3mmol/L; 1 point) discriminated patients without (score 0 to 1, hospital
death 4%) from patients with (score 2 to 4, hospital death 35%, P < 0.001) a high risk of death.
Conclusion.— Hypoalbuminaemia offers powerful additional prognostic information to usual
prognostic variables in older patients with severe, acute HF, and deserves further attention in
multimarker strategies.
© 2011 Elsevier Masson SAS. All rights reserved.
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Résumé
Contexte.— Le taux de mortalité hospitalière est particulièrement élevé dans l’insufﬁsance
cardiaque aiguë (ICA) du sujet âgé, et une stratégie basée sur plusieurs marqueurs biologiques
pourrait contribuer à l’identiﬁcation des sujets les plus à risque.
Objectif.— Évaluer la valeur pronostique de l’albumine sérique et du cholestérol total chez le
sujet âgé en ICA sévère.
Méthodes.— Les paramètres biologiques usuels ont été dosés à l’admission chez 207 patients
consécutifs de plus de 70 ans. L’albumine sérique et le cholestérol total ont été dosés lors de
la stabilisation clinique.
Résultats.— La mortalité hospitalière était de 19%. Les patients décédés et survivants étaient
similaires en terme d’âge, de sexe, de fréquence cardiaque, d’hémoglobine sérique et de frac-
tion d’éjection. Les patients décédés avaient des concentration en peptide natriurétique de
type B (BNP), urée plasmatique, créatinine sanguine, protéine C réactive et troponine I plus
élevées, d’albumine sérique et de cholestérol total plus basses (p < 0,01). L’albumine sérique
était le facteur prédictif indépendant de mortalité le plus puissant (OR 0,82 [0,74—0,90],
p < 0,001), avec l’urée (p = 0,02) et le BNP (p = 0,02). Un score de risque basé sur l’albumine
sérique (< 3 g/dL ; 2 points), le BNP (> 840 pg/mL ; 1 point) et l’urée (> 15,3mmol/L ; 1 point)
séparait les patients à bas risque (score 0 à 1, mortalité de 4%) des patients à haut risque
(score 2 à 4, mortalité de 35%).
Conclusion.— L’albumine sérique offre une information pronostique pertinente chez le sujet
âgé hospitalisé en ICA sévère, et mérite d’être intégré plus largement dans les algorithmes
pronostiques.
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Background
Acute HF syndromes are one of the most frequent causes of
admission to community hospitals in developed countries.
This epidemic medical condition primarily affects older
patients and carries high hospital mortality rates [1,2]. Many
elderly patients hospitalized with HF do not beneﬁt from
cardiologist care [3], and may therefore experience poorer
outcomes [4]. Severe symptoms and high concentrations of
BNP are well-established landmarks of severe, acute HF at
hospital admission [5]. A targeted multimarker strategy may,
however, be helpful in improving the identiﬁcation of older
patients at high risk of hospital death, who are candidates
for cardiologist care and tailored unloading therapy.
Serum albumin and serum TC are two simple and inex-
pensive markers of malnutrition-inﬂammation syndrome,
which have been recently proposed for the identiﬁcation of
patients with acute HF at risk of adverse outcome [6—11];
however, it is unknown whether these two biomarkers offer
relevant prognostic information incremental to usual prog-
nosticators in older patients with severe, acute HF. The
present study addressed the prognostic relevance of serum
albumin and serum TC in the prediction of hospital death
in older patients identiﬁed as having severe, acute HF at
admission to a French community hospital.
l
ﬁ
ss droits réservés.
ethods
tudy population
his prospective, observational study included consecu-
ive elderly patients aged > 70 years, who were admitted
o the Department of Cardiology of our institution from
anuary 2009 to February 2011 with the primary diagno-
is of acute HF. All the patients had acute dyspnoea at
est, clinical and radiographic signs of pulmonary oedema,
hich responded favourably to intravenous furosemide ther-
py, and abnormal concentrations of BNP. Comprehensive
oppler echocardiography was performed in all patients
ithin 24 h of admission. Because low and intermediate
NP concentrations indicate good prognosis at the time of
dmission, all patients with BNP concentrations < 300 pg/mL
ssociated with a LV ejection fraction > 50%, as well as
ll patients with BNP concentrations < 600 pg/mL associated
ith a LV ejection fraction < 50%, were not included in the
tudy [5]. Other exclusion criteria were acute coronary
yndromes, acute myocardial infarction with ST-segment
levation, severe left-sided valve disease, neoplasia and
iver cirrhosis. Finally, 207 consecutive patients with the
nal diagnosis of severe, acute HF were included in the
tudy. All patients were managed by two HF specialists dur-
5i
h
t
p
i
B
B
s
1
s
5
R
5
t
6
s
i
p
v
a
3
s
p
v
w
i
o
c
s
c
(
(
a
f
e
e
c
s
L
t
i
D
t
p
S
D
m
m
I
t
t
i
a
c
t
v
t
c
s
w
h
r
s
n
T
t
d
d
c
a
R
i
d
a
t
w
p
s
(
p
R
B
p
T
7
a
M
1
(
c
h
4
p
a
s
w
d
s
e
h
t
c
a
V
t
T
a
[04
ng their hospital stay. Patients were discharged from the
ospital provided that they were clinically stable under oral
herapy for at least 2 days, without residual pulmonary and
eripheral ﬂuid overload. All patients were included after
nformed consent was obtained.
aseline patient data
aseline clinical data, serum sodium concentration (Dimen-
ion RXL system, Siemens, Munich, Germany; normal range
37 to 145mmol/L), BNP concentration (Architect I1000
ystem, Abbott Diagnostics, Abbott Park, IL, USA; 10 to
000 pg/mL), serum creatinine concentration (Dimension
XL system; normal range 71—115mol/L for men and
3—88mol/L for women), blood urea nitrogen concen-
ration (Dimension RXL system; normal range 2.5 to
.4mmol/L), serum haemoglobin concentration (XE2100
ystem, Sysmex, Kobe, Japan; normal range 13 to 17 g/dL
n men and 12 to 16 g/dL in women) and serum tro-
onin I concentration (Dimension RXL system; normal
alue < 0.14 pg/mL) were collected on admission. Serum
lbumin concentration (Dimension RXL system; normal range
.5 to 5 g/dL), serum TC concentration (Dimension RXL
ystem; normal range 135 to 250mg/dL) and C-reactive
rotein concentration (Dimension RXL system; normal
alue < 3mg/L) were measured in the same blood sample
ithin 3 days of admission, after clinical stabilization. Clin-
cally relevant hypoalbuminaemia was deﬁned by a value
f < 3 g/dL [12]. Creatinine clearance (mL/minute) was cal-
ulated according to the MDRD formula, which integrates
erum creatinine concentration, age and sex but not weight.
The Boston score for congestive HF was calculated by a
ardiologist at admission. This score is based on symptoms
0—4 points), physical examination (0—4) and chest X-ray
0—4). As all of the patients presented with dyspnoea at rest
nd radiographic pulmonary oedema, their scores ranged
rom 7 to 12. All patients underwent comprehensive Doppler
chocardiography at the bedside within 24 h of admission. LV
jection fraction was measured by Simpson’s method; the
ombination of visual estimate and endocardial fractional
hortening was used in patients with poor echogenicity. An
V ejection fraction≥ 50% was used to deﬁne normal LV sys-
olic function. Diastolic function was assessed in patients
n sinus rhythm by the analysis of mitral ﬁlling and tissue
oppler imaging at the mitral annulus. Diastolic dysfunc-
ion was classiﬁed as abnormal relaxation of mitral ﬁlling,
seudonormal mitral ﬁlling and restrictive mitral ﬁlling.
tatistical analysis
escriptive data with normal distribution are given as
ean± standard deviation. Descriptive data without nor-
al distribution are given as median [interquartile range].
ntergroup comparison used the analysis of variance test,
he Kruskal-Wallis test, the Chi2 test and Fisher’s exact
est with bilateral formulation as appropriate. The prespec-
ﬁed endpoint was hospital death. The analysis of variables
ssociated with length of hospital stay in patients dis-
harged alive was designed retrospectively, at the end of
he study. Multiple regression analysis was used to identify
ariables that were associated with serum albumin concen-
ration and serum TC concentration, and the correlation
a
C
n
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oefﬁcient (r) was provided for variables that achieved
tatistically signiﬁcant results. Logistic regression analysis
as used to determine predictors of hospital death, using
ospital death as the dependent variable and age, sex, heart
ate, systolic blood pressure, LV ejection fraction, log (BNP),
erum troponin I, serum sodium, serum creatinine, creati-
ine clearance, blood urea nitrogen, serum albumin, serum
C and C-reactive protein as independent variables. Mul-
ivariable stepwise logistic regression analysis was used to
etermine variables that independently predicted hospital
eath; a variable was entered into the model if its asso-
iated signiﬁcance level was < 0.05 and was removed if its
ssociated signiﬁcance level was > 0.1. The area under the
OC curve in the prediction of hospital death was given with
ts 95% conﬁdence interval. Variables that were indepen-
ently associated with hospital death were used to create
risk score by assigning a speciﬁc number of points propor-
ional to regression coefﬁcients. Multiple regression analysis
as used to identify predictors of hospital length of stay in
atients discharged alive. A P value < 0.05 was considered
tatistically signiﬁcant. Medcalc® software, version 11.1.0.0
Medcalc® Software, Mariakerke, Belgium) was used for the
urpose of statistical analysis.
esults
aseline characteristics of the study
opulation
he mean age of the study population was 86± 7 (range
1—102) years. Median LV ejection fraction was 55% [40—65]
nd 144 patients (70%) had normal LV systolic function.
ean serum albumin concentration was 3.05± 0.5 (range
.47—4.52) g/dL and median serum TC was 170 [140—200]
range 70—330) mg/dL. Ninety-seven patients (47%) had
linically relevant hypoalbuminaemia and 45 patients (22%)
ad hypocholesterolaemia. Among patients in sinus rhythm,
2% had a restrictive mitral ﬁlling pattern, 33% had
seudonormal mitral ﬁlling and 25% had abnormal relax-
tion mitral ﬁlling. Forty patients died during their hospital
tay, soon after a short period of clinical improvement: 32
ith refractory congestive HF and eight with sudden cardiac
eath. Twenty-seven patients (67%) who died had normal LV
ystolic function. None of the patients died from causes of
xtracardiac origin during their hospital stay. The length of
ospital stay was signiﬁcantly shorter in patients who died
han in those discharged alive (P < 0.001). Baseline clini-
al characteristics of the patients are displayed in Table 1
ccording to outcome.
ariables associated with serum albumin and
otal cholesterol concentrations
here was a signiﬁcant linear correlation between serum
lbumin concentration and serum TC concentration (r = 0.43
0.31—0.53], P < 0.001). Serum albumin concentration was
ssociated with a history of dementia (r = 0.17, P = 0.01),
-reactive protein (r =−0.53, P < 0.001), serum creati-
ine (r =−0.17, P = 0.01), log (BNP) (r =−0.15, P = 0.03)
nd serum haemoglobin (r = 0.14, P = 0.03). Serum albumin
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Table 1 Baseline characteristics of patients according to hospital outcome.
Variable Survivors
(n = 167)
Non-survivors
(n = 40)
p
Age (years) 86± 7 87± 7 0.4
Women 112 (67) 28 (70) 0.8
Presenting characteristics
Boston score 10.1± 1.5 10± 1.7 0.8
Systolic blood pressure (mmHg) 152± 34 132± 36 < 0.01
Sinus rhythm 93 (56) 17 (43) 0.2
Heart rate (beats per minute) 83 [69—100] 90 [72—110] 0.09
LV ejection fraction (%) 55 [40—65] 55 [37—65] 0.8
BNP concentration (pg/mL) 919 [660—166] 1194 [757—2790] < 0.01
Serum sodium (mmol/L) 138 [136—141] 140 [134—144] 0.2
Serum creatinine (mol/L) 102 [84—134] 134 [89—203] 0.01
Creatinine clearance (mL/minute) 50 [37—63] 35 [25—56] < 0.01
Blood urea nitrogen (mmol/L) 9.2 [7—12.6] 14.1 [9.6—23.5] < 0.001
Serum haemoglobin (g/dL) 12.1± 1.8 12± 1.9 0.6
Positive serum troponin I 26 (15) 15 (38) < 0.01
C-reactive protein (mg/L) 38 [14—85] 143 [41—208] < 0.001
Serum albumin concentration (g/dL) 3.1± 0.5 2.6± 0.5 < 0.001
Serum total cholesterol concentration (mg/dL) 174 [143—204] 146 [119—172] < 0.001
Medical history
Congestive heart failure 70 (42) 14 (35) 0.5
Hypertension 111 (66) 22 (55) 0.2
Coronary artery disease 53 (32) 16 (40) 0.4
Stroke 31 (18) 5 (12) 0.5
Diabetes mellitus 35 (21) 13 (32) 0.1
Pulmonary disease 28 (17) 6 (15) 0.9
Dementia 39 (23) 14 (35) 0.2
Institutionalized status 80 (48) 21 (52) 0.7
Chronic medications
Diuretics 93 (56) 24 (60) 0.7
ACE-I or ARB 75 (45) 17 (42) 0.9
Beta-blocker 65 (39) 17 (42) 0.8
Statin 23 (14) 6 (15) 0.9
Length of hospital stay (days) 10 [7—13] 6 [4—9] < 0.001
Data are mean± standard deviation, mean [interquartile range] or number (%). ACE-I: angiotensin-converting enzyme inhibitor; ARB:
angiotensin-receptor blocker; BNP: B-type natriuretic peptide; LV: left ventricular.
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iconcentration was not associated with age (P = 0.5), sex
(P = 0.3), a history of HF (P = 0.6), the institutionalized status
(P = 0.07), LV ejection fraction (P = 0.3) or diuretic ther-
apy (P = 0.9). Variables that were independently associated
with serum albumin concentration were C-reactive protein
(P < 0.001) and serum haemoglobin (P = 0.01).
Serum TC concentration was associated with sex (r = 0.21,
P = 0.002), LV ejection fraction (r = 0.16, P = 0.02), C-reactive
protein (r =−0.25, P < 0.001), serum creatinine (r =−0.17,
P = 0.01), log (BNP) (r =−0.16, P = 0.02) and statin ther-
apy (r = 0.27, P < 0.001). Serum CT was not associated
with age (P = 0.8), history of HF (P = 0.1), institution-
alized status (P = 0.055), history of dementia (P = 0.07),
serum haemoglobin (P = 0.9) or diuretic therapy (P = 0.09).
Variables independently associated with serum TC concen-
tration were C-reactive protein (P < 0.001), statin therapy
(P = 0.002) and sex (P = 0.02).
(
p
t
merum albumin, serum total cholesterol and
ospital death
erum albumin (P < 0.001), serum TC (P < 0.001), C-reactive
rotein (P < 0.001) and blood urea nitrogen (P < 0.001) were
he best predictors of hospital death in the univariate model
Table 2). In the ﬁrst step, all the signiﬁcant variables,
xcept for serum albumin, were entered into the multi-
ariable model. C-reactive protein (P = 0.001), blood urea
itrogen (P = 0.005) and serum TC (P = 0.03) were indepen-
ent predictors of hospital death. In the second step, all
he signiﬁcant variables, except for serum TC, were entered
nto the multivariable model. Serum albumin (P < 0.001), log
BNP) (P = 0.02) and blood urea nitrogen (P = 0.02) were inde-
endent predictors of hospital death. In the third step, all
he signiﬁcant variables were entered into the multivariable
odel. Serum albumin (P < 0.001), log (BNP) (P = 0.02) and
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Table 2 Stepwise logistic regression analysis: predictors of hospital death.
Variable Univariate model Area under the ROC curve [95% CI] Multivariable model
OR [95% CI] P OR [95% CI] P
Age 1.02 [0.97—1.07] 0.4 0.54 [0.47—0.61] —
Sex 1.14 [0.54—2.52] 0.7 0.51 [0.44—0.58] —
Heart rate 1.01 [0.99—1.02] 0.1 0.58 [0.51—0.65] —
Systolic blood pressure 0.98 [0.97—0.99] 0.002 0.65 [0.58—0.71] NS
LV ejection fraction 1.00 [0.97—1.01] 0.5 0.51 [0.44—0.58] —
Serum sodium 1.05 [0.99—1.11] 0.07 0.56 [0.49—0.63] —
Log (BNP) 7.8 [2.13—28.6] 0.002 0.64 [0.57—0.70] 5.1 [1.2—21.7] 0.02
Serum creatinine 1.007 [1.003—1.01] 0.001 0.63 [0.56—0.70] NS
Creatinine clearance 0.97 [0.95—0.99] 0.009 0.61 [0.54—0.68] NS
Blood urea nitrogen 1.1 [1.05—1.15] < 0.001 0.72 [0.65—0.78] 1.06 [1.009—1.1] 0.02
Serum troponin I 3.5 [1.6—7.83] 0.002 0.62 [0.55—0.70] NS
C-reactive protein 1.01 [1.005—1.013] < 0.001 0.73 [0.66—0.78] NS
Serum albumin 0.79 [0.72—0.87] < 0.001 0.78 [0.72—0.83] 0.82 [0.74—0.90] < 0.001
Serum total cholesterol 0.51 [0.35—0.73] < 0.001 0.69 [0.62—0.75] NS
BNP: B-type natriuretic peptide; CI: conﬁdence interval; LV: left ventricular; OR: odds ratio; ROC: receiver operating characteristic.
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nlood urea nitrogen (P = 0.02) were independent predictors
f hospital death (Table 2). Clinically relevant hypoalbu-
inaemia < 3 g/dL was 82.5% sensitive and 61.7% speciﬁc in
he prediction of hospital death.
Serum albumin was a strong predictor of hospital death
n patients with normal LV systolic function (odds ratio
.77 [0.69—0.86], P < 0.001; area under the ROC curve
.81 [0.73—0.87]) and in those with LV systolic dysfunc-
ion (odds ratio 0.83 [0.72—0.96], P = 0.01; area under the
OC curve 0.73 [0.60—0.83]). Serum TC predicted outcome
n patients with normal LV systolic function (odds ratio
.48 [0.31—0.76], P = 0.001; area under the ROC curve 0.71
0.63—0.78]). However, serum TC did not clearly predict hos-
ital death in patients with LV systolic dysfunction (P = 0.08).
isk score in the prediction of hospital death
e assigned the following points to the independent pre-
ictors of hospital death in the multivariable model,
sing standard cut-off values from the ADHERE reg-
stry for BNP and blood urea nitrogen [5,13—17]: BNP
oncentration > 840 pg/mL (1 point), blood urea nitro-
en > 15.3mmol/L (1 point) and serum albumin concentra-
ion < 3 g/dL (2 points). Patients with a score of 0 to 1
n = 103) had a hospital mortality rate of 4% compared with
hospital mortality rate of 35% in patients with a score of 2
o 4 (n = 104) (P < 0.001).
erum albumin, serum total cholesterol and
ength of hospital stay
n patients discharged alive, the length of hospi-
al stay was predicted by serum albumin (r =−0.27,
< 0.001), serum haemoglobin (r =−0.24, P = 0.002), serum
C (r =−0.18, P = 0.02) and C-reactive protein (r =−0.15,
= 0.04) (Table 3). Serum albumin (P = 0.004) and serum
aemoglobin (P = 0.01) independently predicted the length
f hospital stay in the multivariable analysis.
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riscussion
cute HF syndromes carry disturbing hospital mortality
ates, which increase with advancing age and illness. The
ospital mortality rate is reported to exceed 10—20% in octo-
enarians and nonagenarians hospitalized with HF [1,2]. As
xpected, the hospital mortality rate was high in the present
tudy (19%), which focused on older patients with a severe
linical picture and elevated concentrations of BNP. Sev-
ral contributors to adverse outcome have been recently
dentiﬁed in acute HF syndromes, including the specialty
f the attending physician [4], in-hospital treatment delay
13] and residual ﬂuid overload [14]. Accurately identify-
ng older patients at high risk may help to improve the
herapeutic management through cardiologist care and tai-
ored unloading therapy. The landmark ADHERE registry has
ell established the prognostic relevance of several simple
arkers in the prediction of hospital death in acute HF syn-
romes, such as systolic blood pressure, BNP, troponin I and
enal failure [5,15—17]. We addressed the clinical relevance
f serum albumin and serum TC on top of the usual prog-
ostic variables, because abnormal concentrations of these
wo biomarkers of malnutrition-inﬂammation syndrome are
ommon in elderly patients and patients with HF, and indi-
ate poor prognosis [6—11,18—20]. In the present study,
he prevalence of clinically relevant hypoalbuminaemia was
7%, which is similar to that reported in a previous study
10]. A few retrospective works have previously suggested
hat serum albumin may predict adverse outcome in patients
ith HF, independent of natriuretic peptides. Hypoalbu-
inaemia was the strongest predictor of hospital death
n 349 elderly patients hospitalized with HF, after adjust-
ng for prior HF hospitalization, serum sodium, blood urea
itrogen and BNP [9]. Serum albumin was the sole, indepen-
ent predictor of mid-term outcome in 146 nonagenarians
ospitalized with HF, after adjusting for BNP and routine
aboratory tests [11]. However, these two studies had a ret-
ospective design and the relation of serum albumin and
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Table 3 Multiple regression analysis: predictors of length of stay in patients discharged alive.
Variable Univariate model P value Multivariable model P value
Age 0.6 —
Sex 0.3 —
Systolic blood pressure 0.1 —
LV ejection fraction 0.1 —
Serum sodium 0.2 —
Log (BNP) 0.07 —
Serum haemoglobin 0.002 0.01
Serum creatinine 0.4 —
Creatinine clearance 0.5 —
Blood urea nitrogen 0.2 —
Serum troponin I 0.1 —
C-reactive protein 0.04 NS
Serum albumin < 0.001 0.004
Serum total cholesterol 0.02 NS
BNP: B-type natriuretic peptide; LV: left ventricular.
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tserum TC to cardiac death was not studied. Furthermore,
the inﬂuence of LV ejection fraction on the ability of serum
albumin to predict outcome was not speciﬁcally addressed.
This latter concern is of major importance because the
prognostic usefulness of serum albumin has been recently
questioned in patients with a preserved LV systolic function
[10]. In the present study, median serum TC concentration
was higher than that previously reported in patients with
acute HF [8]. However, serum TC concentration is inﬂuenced
by lipid-lowering medication, and such a chronic treatment
was prescribed signiﬁcantly less frequently in our patients
(14% versus 46%). To the best of our knowledge, no study has
addressed the prognostic relevance of serum TC in patients
with HF and increased concentrations of BNP. In the present
study, usual prognosticators at admission predicted hospi-
tal cardiac death in elderly patients with severe, acute HF.
Serum albumin offered more relevant prognostic informa-
tion incremental to all these usual variables than serum
TC. Serum albumin predicted hospital cardiac death in sys-
tolic and diastolic HF. Hypoalbuminaemia was independently
linked to longer length of hospital stay in patients discharged
alive, which is consistent with other observational studies
[18,21].
The prognostic relevance of serum albumin and serum
TC probably refers to underlying malnutrition, inﬂamma-
tion and wasting syndrome [22,23]. The strong, independent
prognostic value of serum albumin may, however, illus-
trate its contribution to the progression of HF. Serum
albumin is an abundant plasma protein with multiple
physiological properties, including colloid osmotic effect,
antioxidant and anti-inﬂammatory functions, and bind-
ing capacity for many molecules and drugs [6]. Growing
evidence suggests that severe hypoalbuminaemia exerts
adverse pleiotropic effects on many organs and neurohu-
moral systems that are involved in the clinical syndrome of
HF [6]. Hydrostatic capillary and plasma oncotic pressures
are the main opposing forces that regulate ﬂuid balance
across the capillary membrane and there is deﬁnite evi-
dence that severe hypoalbuminaemia promotes pulmonary
oedema [6]. Serum albumin contributes to maintain the
h
w
a
antegrity of the myocardial microvasculature through its
ncotic properties and its interaction with the endothe-
ial glycocalyx [6]. Severe hypoalbuminaemia aggravates
yocardial oedema, which is considered as a cause of
yocardial dysfunction and electrophysiological instability
n many heart diseases [6,24,25]. Serum albumin proper-
ies include antioxidant and anti-inﬂammatory functions
6,26,27], and severe hypoalbuminaemia may exacerbate
xidative stress and inﬂammation, which are involved in the
lobal process of HF. Severe hypoalbuminaemia contributes
o volume overload through the activation of baroreceptors
nd diuretic resistance [6], and residual ﬂuid overload is
inked to adverse outcome in the setting of congestive HF
14,28].
The present study highlights the relevance of a simple
nd inexpensive biomarker on top of usual prognostic vari-
bles, through a multimarker strategy, in older patients
ospitalized with severe, acute HF. The combination of
erum albumin, BNP and blood urea nitrogen through a
imple risk score enabled the identiﬁcation of a subgroup
f patients at very high risk of hospital death (35%).
uch patients may beneﬁt from cardiologist care and tai-
ored unloading therapy. Because severe hypoalbuminaemia
otentially contributes to diuretic resistance and volume
verload [6], further studies are needed to evaluate the
afety and beneﬁts of ultraﬁltration and targeted albu-
in administration associated with furosemide therapy in
ypoalbuminaemic patients with refractory congestive HF
12,28—30].
tudy limitations
he major limitation of the present study is that clinical
arkers of malnutrition were not studied, while malnu-
rition and inﬂammation are the main determinants of
ypoalbuminaemia. The prognostic value of body mass index
as not addressed because the patient’s weight was not
vailable in patients with in-hospital fatal outcome as well
s in bedridden patients. For the same reason, the Cockroft
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ormula was not used to calculate creatinine clearance in
ur study. The risk score in the prediction of hospital death
hould be validated in further prospective studies. Further
tudies are also needed in younger patient populations to
etermine the prognostic relevance of serum albumin and
erum TC additional to usual prognostic markers.
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